1. A Population Pharmacokinetic Model for Vancomycin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Therapy. (17th September 2016) Authors: Moore, JN; Healy, JR; Thoma, BN; Peahota, MM; Ahamadi, M; Schmidt, L; Cavarocchi, NC; Kraft, WK Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 5:Number 9(2016:Sep.) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Model‐Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti–PD‐1 Monoclonal Antibody in Advanced Solid Tumors. (14th November 2016) Authors: Ahamadi, M; Freshwater, T; Prohn, M; Li, CH; de Alwis, DP; de Greef, R; Elassaiss‐Schaap, J; Kondic, A; Stone, JA Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 1(2017) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma. (5th November 2016) Authors: de Greef, R; Elassaiss‐Schaap, J; Chatterjee, M; Turner, DC; Ahamadi, M; Forman, M; Cutler, D; de Alwis, DP; Kondic, A; Stone, J Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 1(2017) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab‐Treated Advanced Melanoma. (29th November 2016) Authors: Chatterjee, MS; Elassaiss‐Schaap, J; Lindauer, A; Turner, DC; Sostelly, A; Freshwater, T; Mayawala, K; Ahamadi, M; Stone, JA; de Greef, R; Kondic, AG; de Alwis, DP Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 1(2017) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗